Masimo (NASDAQ:MASI) Shares Down 1.8%

Shares of Masimo Co. (NASDAQ:MASI) dropped 1.8% during mid-day trading on Tuesday . The company traded as low as $136.77 and last traded at $136.98. Approximately 37,721 shares were traded during trading, a decline of 94% from the average daily volume of 607,544 shares. The stock had previously closed at $139.43.

Analyst Ratings Changes

A number of analysts have recently commented on the company. Piper Sandler boosted their price objective on Masimo from $70.00 to $117.00 and gave the company a “neutral” rating in a research report on Monday, February 26th. BTIG Research boosted their price target on shares of Masimo from $145.00 to $166.00 and gave the stock a “buy” rating in a report on Monday. Needham & Company LLC downgraded shares of Masimo from a “buy” rating to a “hold” rating in a report on Wednesday, January 3rd. Stifel Nicolaus boosted their target price on shares of Masimo from $125.00 to $148.00 and gave the stock a “hold” rating in a research note on Monday. Finally, Jefferies Financial Group reaffirmed a “hold” rating and issued a $121.00 price target (up from $107.00) on shares of Masimo in a research note on Tuesday, January 30th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, Masimo currently has a consensus rating of “Hold” and an average target price of $134.29.

Masimo Stock Up 2.7 %

The company has a quick ratio of 1.22, a current ratio of 2.18 and a debt-to-equity ratio of 0.64. The company has a market capitalization of $7.64 billion, a PE ratio of 95.68 and a beta of 0.95. The firm has a 50-day moving average of $131.76 and a two-hundred day moving average of $109.26.

Masimo (NASDAQ:MASI) last issued its quarterly earnings data on Tuesday, February 27th. The medical equipment provider reported $1.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.82 by $0.43. The firm had revenue of $548.90 million during the quarter, compared to the consensus estimate of $545.69 million. Masimo had a return on equity of 13.77% and a net margin of 3.98%. The company’s quarterly revenue was down 11.0% on a year-over-year basis. During the same period last year, the company earned $1.32 EPS. Equities research analysts predict that Masimo Co. will post 3.51 earnings per share for the current fiscal year.

Institutional Trading of Masimo

Institutional investors have recently added to or reduced their stakes in the stock. American Century Companies Inc. boosted its position in shares of Masimo by 2.3% during the first quarter. American Century Companies Inc. now owns 8,799 shares of the medical equipment provider’s stock worth $1,281,000 after buying an additional 194 shares during the period. Great West Life Assurance Co. Can boosted its holdings in Masimo by 24.0% during the 1st quarter. Great West Life Assurance Co. Can now owns 59,540 shares of the medical equipment provider’s stock valued at $9,049,000 after acquiring an additional 11,543 shares during the period. Dimensional Fund Advisors LP grew its position in Masimo by 3.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 226,526 shares of the medical equipment provider’s stock valued at $32,977,000 after acquiring an additional 8,501 shares in the last quarter. Canada Pension Plan Investment Board increased its stake in Masimo by 1,011.6% during the first quarter. Canada Pension Plan Investment Board now owns 2,390 shares of the medical equipment provider’s stock worth $348,000 after purchasing an additional 2,175 shares during the period. Finally, Vanguard Group Inc. boosted its stake in shares of Masimo by 1.5% in the first quarter. Vanguard Group Inc. now owns 4,775,660 shares of the medical equipment provider’s stock valued at $695,050,000 after purchasing an additional 71,918 shares during the period. Institutional investors and hedge funds own 85.96% of the company’s stock.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.